Valsartan and Po2 increased - a phase IV clinical study of FDA data

Summary:

Po2 increased is reported as a side effect among people who take Valsartan (valsartan), especially for people who are male, 60+ old, have been taking the drug for 2 - 5 years also take Valsartan And Hydrochlorothiazide, and have Arteriosclerosis coronary artery.

The phase IV clinical study analyzes which people have Po2 increased when taking Valsartan. It is created by eHealthMe based on reports of 62,763 people who have side effects when taking Valsartan from the FDA, and is updated regularly.

What is Valsartan?

Valsartan has active ingredients of valsartan. It is often used in high blood pressure. eHealthMe is studying from 63,805 Valsartan users. Check the latest studies of Valsartan.

What is Po2 increased?

Po2 increased is found to be associated with 132 drugs and 265 conditions by eHealthMe. Check the latest studies of Po2 increased.

On Aug, 11, 2026

62,763 people reported to have side effects when taking Valsartan.
Among them, 30 people (0.05%) have Po2 increased.

Among these 30 people:

How long have people been on Valsartan when they have Po2 increased? *

What is the gender of people who have Po2 increased when taking Valsartan? *

female: 14.81 %
male: 85.19 %

What is the age of people who have Po2 increased when taking Valsartan? *

What are other drugs people take besides Valsartan? *

Valsartan And Hydrochlorothiazide: 18 people, 60.00%
Aspirin: 13 people, 43.33%
Metoprolol Succinate: 9 people, 30.00%
Pantoprazole Sodium: 9 people, 30.00%
Diclofenac Sodium: 9 people, 30.00%
Exforge Hct: 9 people, 30.00%
Clarithromycin: 9 people, 30.00%
Cromolyn Sodium: 9 people, 30.00%
Rasilez: 9 people, 30.00%
Simvastatin: 9 people, 30.00%

What are other side effects people have besides Po2 increased? *

Pco2 Decreased: 30 people, 100.00%
White Blood Cell Count Increased: 26 people, 86.67%
Productive Cough: 26 people, 86.67%
Hypoaesthesia (reduced sense of touch or sensation): 26 people, 86.67%
Helicobacter Gastritis (inflammation of the inner lining of the stomach caused by helicobacter pylori (h. pylori) a bacterium): 26 people, 86.67%
Night Sweats (sweating in night): 26 people, 86.67%
Haemoglobin Decreased: 26 people, 86.67%
Oxygen Saturation Increased: 26 people, 86.67%
Pain: 26 people, 86.67%
Haematocrit Decreased: 26 people, 86.67%

What are the existing conditions these people have? *

Arteriosclerosis Coronary Artery (thickening and hardening of arteries- coronary artery): 21 people, 70.00%
Muscle Spasms (muscle contraction): 8 people, 26.67%
Actinic Keratosis (skin disease due to sun exposure): 7 people, 23.33%
Hyperkeratosis (thickening of the outer layer of the skin): 1 person, 3.33%

* Approximation only. Some reports may have incomplete information.

Do you take Valsartan and have Po2 increased?

- Check whether Po2 increased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Valsartan:

Valsartan (63,805 reports)

Po2 increased treatments and more:

Po2 increased (1,066 reports)

Browse all side effects of Valsartan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Po2 increased:

Po2 increased (132 drugs)

Browse all the conditions that are associated with Po2 increased:

Po2 increased (265 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on valsartan (the active ingredients of Valsartan) and Valsartan (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.